{
    "ticker": "NMRD",
    "name": "Nemaura Medical, Inc.",
    "description": "Nemaura Medical, Inc. is a pioneering medical technology company that focuses on developing and commercializing non-invasive continuous glucose monitoring (CGM) systems and related products. Founded in 2011 and headquartered in the United States, Nemaura aims to transform diabetes management through innovative technologies. The company's flagship product, the sugarBEAT\u00ae system, is designed to provide users with real-time glucose data without the need for finger pricks, enhancing user comfort and compliance. Nemaura's technology leverages advanced sensing and wearable patch technology to enable diabetic patients and healthcare providers to make informed decisions regarding insulin management and lifestyle changes. The company's mission extends beyond just glucose monitoring; Nemaura is committed to improving the quality of life for individuals with diabetes and other metabolic disorders by offering user-friendly solutions that empower patients. In addition to CGM technologies, Nemaura is exploring other applications of its platform, including weight management and obesity treatment, further broadening its impact in the healthcare space. As the prevalence of diabetes continues to rise globally, Nemaura's innovative approach positions it at the forefront of the healthcare technology revolution.",
    "industry": [
        "Medical Technology",
        "Healthcare"
    ],
    "headquarters": "Loughborough, England, UK",
    "founded": "2011",
    "website": "https://www.nemauramedical.com",
    "ceo": "Dr. Faz Chowdhury",
    "social_media": {
        "twitter": "https://twitter.com/NemauraMedical",
        "linkedin": "https://www.linkedin.com/company/nemaura-medical"
    },
    "investor_relations": "https://ir.nemauramedical.com",
    "key_executives": [
        {
            "name": "Dr. Faz Chowdhury",
            "position": "CEO"
        },
        {
            "name": "Dr. J. A. Nemaura",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Glucose Monitoring",
            "products": [
                "sugarBEAT\u00ae System"
            ]
        },
        {
            "category": "Weight Management",
            "products": []
        }
    ],
    "seo": {
        "meta_title": "Nemaura Medical, Inc. | Innovative Diabetes Management Solutions",
        "meta_description": "Explore Nemaura Medical, Inc., a leader in non-invasive glucose monitoring technology. Learn about innovative products designed to improve diabetes management and patient quality of life.",
        "keywords": [
            "Nemaura",
            "Diabetes Management",
            "Glucose Monitoring",
            "sugarBEAT",
            "Healthcare Technology"
        ]
    },
    "faq": [
        {
            "question": "What is Nemaura Medical known for?",
            "answer": "Nemaura Medical is known for its innovative non-invasive glucose monitoring systems, particularly the sugarBEAT\u00ae system."
        },
        {
            "question": "Who is the CEO of Nemaura Medical?",
            "answer": "Dr. Faz Chowdhury is the CEO of Nemaura Medical, Inc."
        },
        {
            "question": "Where is Nemaura Medical headquartered?",
            "answer": "Nemaura Medical is headquartered in Loughborough, England, UK."
        },
        {
            "question": "What products does Nemaura Medical offer?",
            "answer": "Nemaura Medical offers the sugarBEAT\u00ae system for glucose monitoring and is exploring additional health management solutions."
        },
        {
            "question": "When was Nemaura Medical founded?",
            "answer": "Nemaura Medical was founded in 2011."
        }
    ],
    "competitors": [
        "DXCM",
        "ABT",
        "MDGL",
        "OMAB"
    ],
    "related_stocks": [
        "AAPL",
        "MSFT",
        "GOOGL",
        "AMZN"
    ]
}